Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Dec 7:7:150.
doi: 10.1186/s13756-018-0444-8. eCollection 2018.

Alarming levels of antimicrobial resistance among sepsis patients admitted to ICU in a tertiary care hospital in India - a case control retrospective study

Affiliations

Alarming levels of antimicrobial resistance among sepsis patients admitted to ICU in a tertiary care hospital in India - a case control retrospective study

D Nagarjuna et al. Antimicrob Resist Infect Control. .

Abstract

Background: Hospital acquired infections (HAI) are principal threats to the patients of intensive care units. An increase in the antimicrobial resistance (AMR) observed in gram negative bacteria is a great challenge to deal with. HAI and AMR lead to prolonged hospitalization and additional doses of anti-microbial treatment affecting patient's fitness and finances. Present study was undertaken to determine the pathotypes, genetic diversity and the antimicrobial resistance of E.coli in isolates from the patients admitted to intensive care unit at a tertiary care hospital in Delhi, India.

Methods: E.coli isolates (N = 77) obtained from the blood culture of patients diagnosed with sepsis and the isolates (N = 71) from the stool culture of patients admitted in intensive care unit (ICU) but not diagnosed with sepsis were investigated for their pathotypes, adherence patterns and genetic diversity by Enterobacterial Repeated Intergenic Consensus-polymerase chain reaction (ERIC-PCR). A Kirby-Bauer Disc diffusion test and antimicrobial susceptibility assays were performed according to the Clinical and Laboratory Standards Institute (CLSI) guidelines. Extended-spectrum β-lactamase (ESBL) genes and sequence type 131 (ST131) clone were characterised genotypically by gene-specific PCRs.

Results: Pathotypes analysis revealed 46 and 16% of the blood E.coli isolates were ETEC and EAEC respectively, in contrast to the fecal isolates wherein 22% of the isolates were ETEC and 28.5% were EAEC. EPEC, STEC and EIEC pathotypes were not detected in blood or fecal isolates. Of all the isolates studied, more than 90% of the blood and 70% of the fecal isolates were found to be resistant to cephalosporins. On the other hand, 68% of blood and 44% of the fecal isolates were found to be ESBL producers. Interestingly 83% of the blood isolates contained CTX-M15, whereas only 21% of them contained CTX-M9 genes. On the other hand CTX-M15 genes were found in 90% and CTX-M9 genes were found in 63% of the fecal isolates.

Conclusion: The antimicrobial resistant profile found in this study is alarming and poses a great threat to public health. Apparently an increased antimicrobial resistance to the extensively used cephalosporins is affecting an optimal drug therapy for patients. In addition, the presence of catheters, prolonged duration of stay in the hospital and poor hygienic conditions due to infrequent urination of the patient can lead to an additional vulnerability. Therefore continuous surveillance and rational use of antibiotics along with effective hygienic measures are urgently recommended in such settings.

Keywords: Antimicrobial resistance (AMR); Enterobacterial repeated intergenic consensus (ERIC); Escherichia coli; Intensive care unit (ICU); Pathotypes; Sepsis.

PubMed Disclaimer

Conflict of interest statement

This project was approved by the Institutional Ethical Committee of Vardhaman Mahavir Medical College (VMCC) and Safdarjung Hospital (S.No-VMMC/SJH/Ethics/SEP-11/29) and Institute Human Ethics committee of ACBR, University of Delhi, Delhi (S.No. F50–2/Ethic.com/ACBR/2015).Not applicable.The authors declare that they have no competing interests.Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Prevalence of pathotypes in blood and fecal E.coli isolates from sepsis and non-sepsis patients respectively. p value is **p ≤ 0.01. EPEC: Enteropathogenic E.coli; STEC: Shiga toxin-producing E.coli; ETEC: Entero-toxigenic E. coli; EIEC: entero-invasive E.coli; EAEC: Entero-aggregative E.coli
Fig. 2
Fig. 2
a Representative characteristic adherence patterns of E.coli in EAEC and ETEC as seen in HeLa cells upon infection (L: Localized; D: Diffused and A: Aggregative pattern). Scale is 100 μM; b Overall prevalence of adherence patterns in blood and fecal E.coli isolates from sepsis and non-sepsis patients respectively; c Prevalence of adherence patterns among EAEC and ETEC
Fig. 3
Fig. 3
a Phenogram and b Principal component analysis showing the genomic similarity among blood and the fecal E.coli isolates as carried out by computer-assisted ERIC-PCR DNA fingerprint analysis (see material and methods for detail)
Fig. 4
Fig. 4
Antibiotic susceptibility pattern of fecal (a) and blood (b) E.coli isolates from non-sepsis and sepsis patients respectively
Fig. 5
Fig. 5
a Picture representing the antibiotic disc diffusion test for extended spectrum Beta-Lactamase (ESBL) producers. Each circular disc contains the antibiotic of specific concentration. Clear zone around the disc indicates zone of Inhibition. b Prevalence of ESBL producers between blood and fecal E.coli isolates from sepsis and non-sepsis patients respectively. P value is **p = 0.001
Fig. 6
Fig. 6
Comparision of different ESBL genes in blood and fecal E.coli isolates from sepsis and non-sepsis patients respectively using gene specific PCR
Fig. 7
Fig. 7
a Prevalence of ST131 clone b Prevalence of FimH30 and FimH30-Rx sub groups of ST131 clone among blood and fecal E.coli isolates from sepsis and non-sepsis patients respectively. **p = 0.0119

References

    1. Timsit JF, Laupland KB. Update on bloodstream infections in ICUs. Curr Opin Crit Care. 2012;18(5):479–486. doi: 10.1097/MCC.0b013e328356cefe. - DOI - PubMed
    1. Al-Zahrani A, Alsulaimani EEA, Abbadi S. Healthcare Associated Infection in the Neonatal Intensive Care Unit of King Abdl Aziz Specialist Hospital, Taif, KSA. Adv Infect Dis. 2013;3(4):300–305. doi: 10.4236/aid.2013.34046. - DOI
    1. Sheng WH, et al. Impact of nosocomial infections on medical costs, hospital stay, and outcome in hospitalized patients. J Formos Med Assoc. 2005;104(5):318–326. - PubMed
    1. Sheng WH, et al. Comparative impact of hospital-acquired infections on medical costs, length of hospital stay and outcome between community hospitals and medical centres. J Hosp Infect. 2005;59(3):205–214. doi: 10.1016/j.jhin.2004.06.003. - DOI - PubMed
    1. Russo TA, Johnson JR. Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes Infect. 2003;5(5):449–456. doi: 10.1016/S1286-4579(03)00049-2. - DOI - PubMed

Publication types

MeSH terms